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Abstract 
Background: Fortifying human milk contributes to the prevention of postnatal growth failure in preterm infants. 
Because of the natural variability of human milk, targeted fortification of human milk has been advocated. However, 
data regarding the efficacy and safety of prolonged targeted fortification are scarce. We aimed to assess the safety of 
targeted fortification of human milk in preterm infants compared with standard fortification, as well as the effects on 
infant growth.
Methods: We conducted an interventional study during hospital stay in healthy very low birth weight preterm 
infants who were exclusively fed human milk. Pools of human milk collected for 24 h were analysed using mid-
infrared transmission spectroscopy. Targeted fortification of human milk was performed by adding macronutrients 
to native human milk to obtain optimal ratios of fat (4.4 g), carbohydrates (8.8 g), and protein (3 g) per 100 ml. The 
intervention period lasted 4–7 weeks. Weekly weight and daily growth rates were compared with those of a standard-
ized fortification group of very low birth weight preterm infants who received standard fortified human milk (n = 10). 
The osmolality as well as the metabolic and gastrointestinal tolerance were monitored. Intergroup differences were 
evaluated using the Mann–Whitney U-test.
Results: A total of 10 preterm infants (birth weight 1223 ± 195 g; gestational age 29.1 ± 1.03 weeks) were enrolled 
and 118 samples of pooled milk were analysed. On average, 1.4 ± 0.1 g of protein, 2.3 ± 0.5 g of carbohydrate, and 
0.3 ± 0.1 g of fat per 100 ml were added to the milk. Osmolality values after target fortification were within recom-
mended limits (376 ± 66 mOsml/kg). Weekly weight gain (205.5 g; 95 % CI 177–233 vs 155 g; 95 % CI 132–178; 
p = 0.025) and daily growth rates (15.7 g/kg/day; 95 % CI 14.5–16.9 vs 12.3 g/kg/day; 95 % CI 10.7–13.9; p = 0.005) 
were higher in infants receiving target fortification than in infants receiving standardized fortification. The infants 
receiving targeted fortified milk consumed similar volumes as infants in the standardized fortification group 
(148 ± 4.5 vs 146 ± 4 ml/kg/day). No signs of either gastrointestinal or metabolic intolerance were observed.
Conclusions: Target fortification appears to promote growth in very low birth weight preterm infants without any 
detrimental effects.
Trial registration NCT02716337
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Background
The American Academy of Paediatrics recommends that 
the postnatal nutritional management of very low birth 
weight (VLBW, birth weight <1500  g) infants should 
meet the intrauterine rates of foetal growth, i.e., 15  g/
kg/day [1]. However, despite several efforts in recent 
years regarding nutritional support of preterm infants, 
postnatal growth restriction is still common in neona-
tal intensive care units [2]. Increasing evidence indicates 
that adequate postnatal growth is positively associated 
with better neurodevelopmental outcomes [3]. There-
fore, the prevention of postnatal growth restriction in 
preterm infants during hospitalization is of the utmost 
importance.
Breast milk is acknowledged as ideal for the nutritional 
support of preterm infants because of its several health 
benefits on immunological, gastrointestinal and neurode-
velopmental functions
The implementation of human milk feeding has been 
associated with improved feeding tolerance, reduced 
rates of necrotizing enterocolitis, sepsis and retinopathy 
of prematurity, in addition to promotion of neurocogni-
tive development [4].
However, although the protein and energy content of 
breast milk from mothers who delivered prematurely is 
higher than that from mothers of term infants, preterm 
milk does not meet the nutritional requirements of pre-
term infants [5]. Moreover, inter- and intra variability of 
breast milk composition is elevated [6, 7]. To optimize 
the nutritional composition of maternal milk and provide 
preterm infants with adequate intake of macronutrients, 
the addition of commercially available fortifiers, either as 
a single component or multicomponent, has been advo-
cated. Improved growth rates and nutritional param-
eters have been reported in preterm infants exclusively 
fed fortified breast milk compared with preterm infants 
exclusively fed unfortified breast milk [5]. However, forti-
fication of breast milk may cause adverse effects, includ-
ing metabolic acidosis [8]. With regard to osmolality, the 
combination of multicomponent and single component 
fortifiers can cause an increase over the recommended 
upper limits, thus increasing the risk of gastrointestinal 
intolerance [9, 10]. Currently, three strategies of breast 
milk fortification are available [11]. Standard fortifica-
tion is the most commonly used practice of breast milk 
supplementation, which is based on the addition of a 
fixed dose of product and assuming a standard compo-
sition of breast milk. A second approach, called adjust-
able fortification, modulates protein supplementation 
on the basis of blood urea nitrogen levels [12]. The tar-
get fortification strategy is based on the regular analysis 
of breast milk composition, thus allowing for the provi-
sion of adequate individual targeted macronutrients to 
each infant. In recent years, reports have suggested the 
benefits of this customized approach on decreasing the 
variability of maternal milk’s macronutrients [13] and 
improving growth in preterm infants [14, 15]. However, 
studies exploring the efficacy and safety of prolonged tar-
geted fortification compared with standard fortification 
in VLBW preterm infants are still scarce.
The aim of this study was to assess the growth benefits 
of targeted breast milk fortification during the hospital 
stay compared with standard fortification in VLBW pre-
term infants. The hypothesis was that VLBW preterm 
infants receiving targeted fortification would show better 
growth at the time of discharge without adverse effects 
concerning safety and metabolic tolerance.
Methods
Study design and subjects
A prospective interventional study was conducted in 
the NICU of Mangiagalli Clinic in Milan, Italy. Qualify-
ing infants born between October 2014 and March 2015 
were enrolled in the intervention group. Informed writ-
ten consent was obtained from the parents of the partici-
pants before enrolment.
The inclusion criteria were as follows: gestational age 
<32  weeks, birth weight <1500  g and ≥10th percentile 
according to Fenton’s growth chart [16] and exclusively 
consuming breast milk during the entire hospital stay. 
The exclusion criteria were the presence of either con-
genital or chromosomal abnormalities or conditions that 
interfere with growth such as chronic lung disease (as 
defined based on the classification of Jobe and Bancalari 
[17]), neurological disorders, metabolic, cardiac and gas-
trointestinal diseases and/or sepsis, which was defined as 
a positive blood culture.
A flow chart summarizing the study design is shown in 
Fig. 1.
Infants admitted to the same institution during the pre-
vious 6 months (January to June 2014) and who fulfilled 
the inclusion criteria of the study comprised the stand-
ardized fortification group.
Nutritional practices
The nutritional management at our institution did not 
undergo major changes from January 2014 up to the 
intervention period except for the approach to breast 
milk fortification. According to the internal nutritional 
procedure of our institution, parenteral nutrition was 
started immediately after birth in infants in the stand-
ardized fortification and the intervention groups and 
enteral nutrition was administered as soon as possible. 
Nutritional management was similar in the two groups 
up to the initiation of breast milk fortification. Parenteral 
nutrition and minimal enteral feeding was started on 
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the first day of life in all infants. The parenteral solutions 
were prepared by the hospital pharmacy according to 
the prescription. The solutions contained a minimum of 
57 kcal/kg/day with 2.5 g/kg of protein on the first day of 
life and up to 90–100 kcal/kg/day and 4 g/kg/day of pro-
tein within the first week [18].
In both groups, fortification of breast milk was started 
when the enteral intake reached 90  ml/kg/day. The vol-
ume of enteral feeding was increased based on the 
infants’ cardio-respiratory stability and gastrointestinal 
tolerance.
Milk fortification
Infants in the intervention group received individualized 
targeted fortification. To enhance feeding tolerance, tar-
geted fortification was gradually introduced over a 3-day 
period. On day 4, the full amount of the targeted fortifi-
cation for each macronutrient was prescribed. The inter-
vention period lasted until the infant was discharged.
Mothers of enrolled infants collected expressed milk 
in sterile bottles. Every monday and thursday at 7 a.m., 
nurses mixed a bottle containing the milk collected dur-
ing the previous 24  h using a vortex shaker. Approxi-
mately 2 ml of breast milk from each bottle was aliquoted 
for the macronutrient analysis. Prior to composition 
analysis, samples of native breast milk were frozen [19]. 
After 24 h, the thawed milk was homogenized using an 
ultrasonic homogenizer (Sonicator®, Uppsala, Sweden). 
Analyses were performed using a human milk analyser 
(Miris AB®, Uppsala, Sweden) based on mid-infrared 
transmission spectroscopy. The instrument was cali-
brated for breast milk measurements using the Kjeldahl 
method for proteins, HPLC for lactose and the Rose-Got-
tlieb method for fat [19].
The breast milk analyses were conducted twice a week 
because this measurement frequency has been reported 
to adequately compensate the daily nutritional variabil-
ity of breast milk and to ensure a correct mean target of 
nutrient intake [20]. To comply with the guidelines from 
the European Society for Paediatric gastroenterology, 
Hepatology, and Nutrition (ESPGHAN) [21], the tar-
get levels of breast milk macronutrients were as follows: 
3 g/100 ml of protein, 8.8 g/100 ml of carbohydrates, and 
4.4 g/100 ml of fat.
The calculations for target fortification was performed 
in two steps. First, the macronutrient content of native 
breast milk was assessed. The additional protein, fat and 
carbohydrate levels were then calculated on the basis of 
the ESPGHAN recommendations after subtracting the 
native breast milk composition in terms of protein, car-
bohydrates and fat content. The calculated amount of 
fortifiers was immediately added before the milk was 
consumed. The following commercially available pow-
dered fortifiers were used: Infant Vita BMF (Dietetic 
Metabolic Food SRL, Limbiate, Milano, Italy: 48  g pro-
tein/100  g, 22  g fat/100  g, 0,47 carbohydrate/100  g); 
Aptamil BMF (Milupa, Friedrichsdorf, Germany: 25  g 
protein/100  g, 61  g carbohydrate/100  g); Nidex (Nestlé, 
Vevey, Switzerland: maltodextrin, 96 g/100 g); Aptamil PS 
(Milupa, Friedrichsdorf, Germany: 82  g protein/100  g). 
In the standardized fortification group, the milk had not 
been analysed; thus, the standard composition of breast 
milk (protein 1.1 g/100 ml, carbohydrates 7 g/100 ml, and 
lipids 4.1/100 ml) [7] was assumed. A fixed dose of forti-
fier was added to the breast milk according to the manu-
facturer’s instructions. Upon initiation of fortification, 
the full amount of fortifier was used. The following com-
mercially available powdered fortifiers were used for the 
standardized fortification group: Aptamil BMF (Milupa, 
Friedrichsdorf, Germany) and FM85 (Nestlé, Vevey, Swit-
zerland: 20  g protein/100  g, 66  g carbohydrate/100  g). 
The study period of human milk fortification up until the 
time of discharge was considered for comparison with 
the intervention group.
Data collection and growth assessment
Neonatal characteristics of the intervention group (gesta-
tional age, weight, length and head circumference) were 
prospectively recorded. For the standardized fortification 
group, the data were calculated retrospectively from the 
patients’ computerized medical charts.
Gestational age was based on the last menstrual 
period and first-trimester ultra sonogram. Weight, 
58 VLBW infants born between






Fig. 1 Flow chart of the study
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length, and head circumference were measured 
according to standard procedures by the same trained 
nurse [22]. Weight was assessed daily, whereas the 
length and head circumference were assessed weekly. 
Infant mass was measured on an electronic scale 
accurate to the nearest 0.1  g; body length was meas-
ured to the nearest 1  mm on a Harpenden neonato-
meter (Holtain Ltd, UK), and head circumference to 
the nearest 1 mm using a non-stretch measuring tape. 
The changes in weight, length and head circumference 
were calculated weekly.
The daily growth rate was calculated from the start of 
fortification until discharge and was calculated using an 
exponential regression model as follows:
where W = weight in grams; D = day; 1 = beginning of 
the time interval and 2 = end of the time interval [23].
Osmolality, metabolic assessments and gastrointestinal 
tolerance of target fortification
The osmolality of the unfortified and targeted forti-
fied breast milk was measured using a freezing point 
osmometer (Osmometer MIR 300-P, E. Mires, Milan, 
Italy) before milk administration to the infants. Blood 
parameters (urea nitrogen n.v. 15–38  mg/dl, creatinine 
n.v. 0.1–0.7 mg/dl, albumin n.v. 3.8–5.4 g/dl, calcium n.v. 
8.40–10.20  mg/dl, phosphorus n.v. 2.7–6.7  mg/dl and 
alkaline phosphates n.v. <300 U/L levels) were monitored 
weekly.
Clinical features, including signs of feeding intolerance 
(e.g., gastric residual volume >50 % of the previous feed-
ing volume, abdominal distension, enteral feeding inter-
ruption, and emesis episodes) and stool frequency, were 
evaluated daily for each infant.
Statistical analysis
Descriptive data were reported as the mean (standard 
deviation) (95  % confidence interval), and the signifi-
cance level was set at 0.05. The sample size was estimated 
using the daily growth rate. The mean growth rate of the 
infants fed standard fortified breast milk in our unit was 
estimated as 12 ± 3 g/kg/day. With a sample size equal to 
ten and assuming an increase of 3 g/kg/day in the daily 
growth of infants receiving target fortification compared 
with standard fortification, the targeted fortification 
would have resulted in a growth rate of 15 g/kg/day (95 % 
CI 12.9–17.1). For analysis, inter-group differences in the 
growth parameters and the daily growth velocity were 
evaluated using the Mann–Whitney U-test. Statistical 
analysis was performed using the SPSS version 20 soft-
ware (Inc, Chicago, IL).
[1000× ln(W2/W1)]/(D2 − D1)
Results
Ten preterm infants (5 females, 5 males) were enrolled 
in the intervention group. The standardized fortifica-
tion group comprised ten preterm infants (4 females, 6 
males). The basic characteristics of the enrolled infants in 
the two groups were similar at birth and at time of enrol-
ment (Table 1). No significant difference in the baseline 
characteristics between groups was detected.
The duration of parenteral nutrition (days) and the 
day of postnatal life on which enteral feeding was begun 
were similar in the intervention and standardized forti-
fication groups (20.2 ± 6.7 vs 19.2 ± 5.6, 0.75 ± 0.89 vs 
1.1 ± 1.05, respectively). Beginning of fortification (days), 
full enteral feeding achievement (days) and end of inter-
vention (days) did not differ among groups (16.1  ±  3.0 
vs 15.9 ± 3.0, 24.2 ± 7.3 vs 26.8 ± 7.6 and 43.7 ± 7.9 vs 
42  ±  9.8, respectively). By the fifth day after fortifica-
tion, infants in both groups achieved similar feeding 
volumes (160  ±  6.1  ml/kg/day for intervention group 
vs 162  ±  11.2  ml/kg/day for standardized fortification 
group) that were unchanged up until time of discharge. 
The postmenstrual age (weeks) at time of discharge was 
similar in the intervention (37 ± 1.6) and the standard-
ized fortification groups (36.8  ±  1.5). The time frame 
during which human milk was fortified both in the inter-
vention and in the standardized fortification groups was 
similar and lasted 4–7 weeks. For the intervention group, 
a total of 118 samples from 24-hour pooled breast milk 
were analysed. The mean macronutrient content of native 
breast milk of each enrolled infant is shown in Figs. 2, 3, 
4.
The variation of macronutrient content in breast milk 
before and after targeted fortification is shown in Fig. 5. 
For native breast milk, average protein content ranged 
from 1.1 to 1.8 g/100 ml, average fat content from 4.1 to 
5.0 g/100 ml and average carbohydrate content from 5.0 
to 6.8 g/100 ml.
On average, in order to meet ESPGHAN recommenda-
tions, 1.4 ± 0.1 g of protein, 2.3 ± 0.5 g of carbohydrate 
and 0.3 ± 0.1 g of fat per 100 ml were added.
Preterm infants fed targeted fortified breast milk 
showed better growth compared with preterm infants 
who received standard fortified breast milk. Specifically, 
the weekly increase in weight, length, head circumference 
and daily growth rate were higher in the infants in the 
intervention group. The weight and length at discharge 
tended to be higher in the intervention group than in 
the standardized fortification group, whereas the length 
of stay and head circumference at time of discharge were 
similar (Table 2).
The infants enrolled in the intervention group 
showed an adequate metabolic tolerance (urea nitrogen 
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18  ±  1.2  mg/dl, creatinine 0.3  ±  0.2  mg/dl, albumin 
4.2 ±  0.6  mg/dl, calcium 9.40 ±  0.2  mg/dl, phosphorus 
3.2 ±  1.8  mg/dl and alkaline phosphates 258 ±  39 U/L 
levels). In addition, no signs of gastrointestinal intoler-
ance were observed in the infants in the intervention 
group. The osmolality values (mOsm/kg) of the breast 
milk were 300  ±  16 before fortification and 376  ±  66 
after fortification.
Discussion
Our preliminary findings suggest that individualized 
targeted fortification leads to better growth in preterm 
infants compared with standard fortification without 
impairing gastrointestinal and metabolic tolerance. On 
the basis of human milk analysis, the combined addi-
tion of single and multicomponent fortifiers allowed 
the infants in the intervention group to receive the rec-
ommended level of each macronutrient according to 
ESPGHAN guidelines. Targeted fortification considers 
the variability of macronutrients of native breast milk 
and, as a result, limits the risk of macronutrient under-
intake [13]. Under-intake may have occurred in the 
standardized fortification group when using standard 
fortification, resulting in inadequate growth. Human milk 
protein content after standard fortification may fail to 
meet the recommended intake for preterm infants [24]. 
Similarly, probably due to the large variation in the nutri-
tional value of human milk, poor growth rates have been 
reported in infants fed standardly fortified human milk 
[13, 25].
Although the infants in the intervention group showed 
a higher growth rate compared with infants in the stand-
ardized fortification group (with a tendency to achieve 
higher weight and length at time of discharge), the 
length of hospital stay was similar between the groups. 
This result is not surprising if we consider that time of 






Gestational age (weeks) 29.1 (1.03) 29.5 (1.18) 0.5
Weight (g) 1223 (195) 1287 (190) 0.8
Length (cm) 37.2 (3.09) 38.5 (2.26) 0.3
Head circumference (cm) 26.7 (2.84) 27.8 (1.83) 0.5
Enrolment
Gestational age (weeks) 31.4 (0.97) 32.2 (0.63) 0.1
Weight (g) 1412 (231) 1557 (173) 0.3
Length (cm) 38.5 (3.4) 40.2 (2.1) 0.3
Head circumference (cm) 27.3 (2.03) 28.2 (1.13) 0.5
Fig. 2 Mean protein (p) content (g/100 ml) of native breast milk of 
each enrolled subject (S)
Fig. 3 Mean fat (f ) content (g/100 ml) of native breast milk of each 
enrolled subject (S)
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discharge is influenced by other clinical conditions, such 
as the stability of vital parameters, the achievement of 
independent oral feeding and adequate coordinated 
sucking abilities.
In recent years, data regarding the benefits of tar-
geted fortification on preterm infant growth have been 
reported by other authors. Reali et  al. [26] showed that 
the use of targeted fortification led to improved growth 
rates in a cohort of extremely low birth weight infants 
(i.e., gestational age ≤30 weeks) in the absence of adverse 
events. The authors specifically reported a mean daily 
growth rate of 16.04  g/kg/day, which is higher than the 
mean weight increase observed in the present study. 
However, when considering the growth rate of infants 
with a gestational age comparable with that of the 
infants enrolled in the present study, the adjusted rate 
was 14.4 ±  0.75  g/kg/day. Rochow et  al. [14] sought to 
Fig. 4 Mean carbohydrate (c) content (g/100 ml) of native breast 
milk of each enrolled subject (S)
Fig. 5 Average protein (a), fat (b) and carbohydrate (c) content (g/100 ml) in native breast milk (A) and targeted breast milk (B)
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compare the growth pattern of 10 VLBW infants (i.e., 
gestational age <32 weeks) who were fed breast milk for-
tified with targeted fortification for at least 3 weeks with 
a group of infants fed with breast milk fortified accord-
ing to standard procedure, but they did not observe any 
significant differences in the daily growth rate between 
the two groups (19.9 ± 2.7 vs 19.7 ± 3.3 g/kg/day). The 
authors speculate that as the feeding volumes of infants 
fed with standard fortification were significantly higher 
than those of infants in the targeted fortification group, 
greater benefits regarding weight gain might have been 
observed if similar feeding volumes were provided in the 
targeted fortification group. McLeod et al. [27] compared 
the effect of targeted fortification in a group of preterm 
infants on growth velocity in comparison to standard for-
tification and did not find any difference among groups 
(11.4  ±  1.4 vs 12.1  ±  1.6  g/kg/day). Of note, growth 
velocity in both groups was lower than recommended 
(15 g/kg/day) [1].
One strength of our study is that the effect of the tar-
geted fortification was assessed throughout the entire 
hospital stay, allowing us to gain further insight into 
the safety and prolonged benefits of targeted fortifica-
tion on the growth of VLBW preterm infants. The study 
is limited by the relatively small number of enrolled 
infants, although it should be considered that the 
treatment period is relatively long (4–7  weeks, mean 
5.6  ±  0.9  weeks). The limited number of subjects is 
partly due to the strict inclusion criteria, which aimed 
to exclude the conditions that could negatively interfere 
with growth. Furthermore, in our NICU, despite the rec-
ognized benefits of breast milk on several critical neo-
natal outcomes, the percentage of infants exclusively fed 
breast milk is relatively low, in agreement with data from 
several Italian NICUs [28]. Because this was a single cen-
tre study, the findings cannot be generalized; however, it 
should be noted that the findings were not influenced by 
any inconsistency of NICU nutritional management.
Conclusions
These results indicate the feasible implementation of tar-
geted fortification in clinical neonatal practice, although 
targeted fortification implies an extra workload for health 
care professionals.
However, this fortification strategy promotes adequate 
preterm infants weight gain during hospital stay. Consid-
ering the beneficial effects of limiting the postnatal growth 
retardation on later neurodevelopmental and health out-
comes, implementation of targeted fortification of breast 
milk could contribute to the reduction of the burden of 
long-term adverse outcomes associated with prematurity.
Further randomized controlled studies are necessary 
to confirm our results and better explore the efficacy and 
safety of targeted fortification on long-term growth, with 
particular focus on infants at increased risk for retarded 
postnatal growth, such as infants with the lowest birth 
weights and/or affected by comorbidities.
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